Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 17 of 20 for:    E-cigarettes youth

HPV Message Testing and Social Media Campaign

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03747302
Recruitment Status : Enrolling by invitation
First Posted : November 20, 2018
Last Update Posted : August 14, 2019
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Norris Cotton Cancer Center
Information provided by (Responsible Party):
Ardis Olson, MD, Trustees of Dartmouth College

Tracking Information
First Submitted Date  ICMJE November 16, 2018
First Posted Date  ICMJE November 20, 2018
Last Update Posted Date August 14, 2019
Actual Study Start Date  ICMJE December 12, 2018
Estimated Primary Completion Date December 2019   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: November 16, 2018)
Changes in intention to vaccinate their child with HPV vaccine [ Time Frame: pre test immediately before viewing message and post test immediately after viewing message. Approximately one hour. ]
Pre and Post surveys of participants viewing a specific social message
Original Primary Outcome Measures  ICMJE Same as current
Change History Complete list of historical versions of study NCT03747302 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures  ICMJE Not Provided
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE HPV Message Testing and Social Media Campaign
Official Title  ICMJE HPV Message Testing and Social Media Campaign
Brief Summary This project involves a social media campaign to increase parent's knowledge and acceptance of the HPV (human papillomavirus) vaccine. The current vaccine protects against nine types of HPV, including seven that are known to cause cancer. The Centers for Disease Control and Prevention (CDC) estimates that the current HPV vaccine could prevent 90% of cancer cases caused by HPV, including cases of cervical cancer, oropharyngeal (mouth and throat) cancer, anal cancer, and others. About 150 and 104 cases of HPV-associated cancers are diagnosed each year in New Hampshire and Vermont, respectively—many of which could be prevented through vaccination. Currently, only 49.8% of New Hampshire adolescents and 44.3% of Vermont adolescents were not up-to-date for HPV vaccination as of 2016. This social media campaign is testing a set of campaign messages with parents locally and nationally to see which messages are most effective in improving their knowledge and acceptance of the vaccine. A study survey link will monitor the number of people reached and will measure parental intention to get their children vaccinated against HPV.
Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Masking Description:
Participants are not aware of which arm of social messaging they are receiving and whether they are receiving the control message or not
Primary Purpose: Health Services Research
Condition  ICMJE
  • Vaccine
  • Human Papilloma Virus
Intervention  ICMJE
  • Other: Social Media Message about HPV and HPV vaccine
    Messages educate parents with facts about HPV vaccination.
  • Other: Social media message about risk of electronic cigarettes.
    Messages educate parents with facts about electronic cigarettes. This is an attention control group without outcomes obtained.
Study Arms  ICMJE
  • Experimental: HPV Messaging
    Subjects are randomized to receive one of five messages on one of the four themes about HPV vaccination.
    Intervention: Other: Social Media Message about HPV and HPV vaccine
  • Control Message
    Subjects are randomized to receive one of five messages about electronic cigarettes.
    Intervention: Other: Social media message about risk of electronic cigarettes.
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Enrolling by invitation
Estimated Enrollment  ICMJE
 (submitted: November 16, 2018)
1200
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE December 2019
Estimated Primary Completion Date December 2019   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • parents of children 9-14 years old

Exclusion Criteria:

  • non-parents
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE Child, Adult, Older Adult
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03747302
Other Study ID Numbers  ICMJE D18180
3P30CA023108-38S4 ( U.S. NIH Grant/Contract )
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE Not Provided
Responsible Party Ardis Olson, MD, Trustees of Dartmouth College
Study Sponsor  ICMJE Dartmouth-Hitchcock Medical Center
Collaborators  ICMJE
  • National Cancer Institute (NCI)
  • Norris Cotton Cancer Center
Investigators  ICMJE
Principal Investigator: Ardis L Olson, MD Trustees of Dartmouth College
Principal Investigator: Sun Jung Kim, PhD Massey Cancer Center
PRS Account Dartmouth-Hitchcock Medical Center
Verification Date August 2019

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP